C12Y 401/00
Carbon-carbon lyases
Official title: Carbon-carbon lyases (4.1)
C12Y401/00 (Carbon-carbon lyases) appears on 882 US grants and 1,527 published applications in this corpus.
Search patents in C12Y- Granted patents
- 882
- Published applications
- 1,527
- Assignees
- 625
- Inventors
- 3,032
- Latest grant
- 6 Oct 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1995 | 2 | 0 |
| 1996 | 1 | 0 |
| 1997 | 2 | 0 |
| 1998 | 3 | 0 |
| 1999 | 3 | 0 |
| 2000 | 3 | 0 |
| 2001 | 7 | 1 |
| 2002 | 4 | 2 |
| 2003 | 2 | 9 |
| 2004 | 2 | 10 |
| 2005 | 2 | 15 |
| 2006 | 10 | 6 |
| 2007 | 7 | 15 |
| 2008 | 3 | 8 |
| 2009 | 6 | 16 |
| 2010 | 4 | 19 |
| 2011 | 9 | 23 |
| 2012 | 15 | 29 |
| 2013 | 15 | 60 |
| 2014 | 26 | 60 |
| 2015 | 43 | 88 |
| 2016 | 65 | 105 |
| 2017 | 53 | 112 |
| 2018 | 59 | 95 |
| 2019 | 77 | 122 |
| 2020 | 79 | 108 |
| 2021 | 88 | 110 |
| 2022 | 71 | 108 |
| 2023 | 60 | 96 |
| 2024 | 56 | 121 |
| 2025 | 66 | 109 |
| 2026 | 39 | 80 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Acetolactate decarboxylase6 Oct 2026US 12,753,401 B2International N&H Denmark Aps
- Genetic engineering of fungi to modulate tryptamine expression22 Sep 2026US 12,742,160 B2Empyrean Neuroscience, Inc.
- Modulating alkaloid profiles in Nicotiana tabacum22 Sep 2026US 12,742,174 B2Philip Morris Products S. A.
- Method for producing chain unsaturated carboxylic acid compound using phenylalanine ammonia layse15 Sep 2026US 12,735,693 B2Riken
- Process control for 3-hydroxypropionic acid production by engineered strains of aspergillus niger25 Aug 2026US 12,716,079 B2Battelle Memorial Institute
- Modified adeno-associated virus vector and use thereof in treating neurological diseases8 Oct 2026US 2026/0306673 A1Genecombio Ltd.
- Production of carbon compounds1 Oct 2026US 2026/0297505 A1
- Biotechnological production of acetone1 Oct 2026US 2026/0297634 A1Evonik Operations GmbH
- Compositions and methods for using antigen-specific apoptotic dna immunotherapy to prevent and treat side effects resulting from administration of immune checkpoint inhibitors24 Sep 2026US 2026/0285979 A1Aditxt, Inc.
- Genetically encoded system for quantifying rubisco activity in catalyzing carbon fixation24 Sep 2026US 2026/0286368 A1The Scripps Research Institute
Most cited
By later US patents
- AAV-mediated delivery of DNA to cells of the nervous system222US 6,180,613 B2The Rockefeller University · 2001
- Fermentive production of four carbon alcohols125US 7,851,188 B2Butamax(Tm) Advanced Biofuels LLC · 2010
- Methods of treating Parkinson's disease using recombinant adeno-associated vector (rAAV)108US 6,309,634 B1Avigen, Inc. · 2001
- Matrices for drug delivery and methods for making and using the same105US 6,395,299 B1Biostream, Inc. · 2002
- Fermentive production of four carbon alcohols84US 7,993,889 B1Butamax(Tm) Advanced Biofuels LLC · 2011